Hilliard et al. [2] compared the effects of flecainide and tetracaine, a known inhibitor of RyR2, on SR Ca2+ spark and wave production in an intact mouse model of CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.